论文部分内容阅读
一般来说,“看病难、看病贵”更多的是被患者或是医药界的人士所关注,作为经济学家他们看待这个问题,会与其他人有什么不同呢?对药物经济学有着深入研究的归国学者刘国恩教授,长期关注和探究着我国正在进行的医疗改革并对国外医疗卫生体制和机制及其医疗方式有着多方的了解。本刊记者就医疗与经济、药物与经济,以及现在的医疗改革所遇到的一些问题对刘国恩教授进行了专访。
In general, “difficult to see a doctor and expensive to see a doctor” is more concerned by patients or people in the medical community. What do economists think about this issue as different from others? There is an in-depth understanding of pharmacoeconomics. Professor Liu Guoen, a returning scholar of the study, has long been concerned with and inquiring into the ongoing medical reforms in our country and has a multi-dimensional understanding of foreign medical health systems and mechanisms and their medical methods. The journalist conducted an exclusive interview with Prof. Liu Guoen on medical and economic, drug and economic, and current medical reforms.